Skip to main content

Home/ PharmaMics/ Group items tagged #bms

Rss Feed Group items tagged

ramchintamaneni

Bristol-Myers Squibb: Phase III CheckMate-227, Part 1 study ESMO 2019 - 0 views

  •  
    Final data from BMS's Phase III CheckMate-227, Part 1 study was presented at the European Society of Medical Oncology conference in September.
1 - 1 of 1
Showing 20 items per page